Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

NCT05796089 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Extensive-Stage Small-Cell Lung Cancer

Interventions

RADIATION: Thoracic Radiotherapy
DRUG: Etoposide with Carboplatin or Cisplatin
DRUG: Durvalumab

Sponsor

Trans Tasman Radiation Oncology Group

Collaborators

[object Object]